-
EP3743095
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP3743095
| EP3743095 - METHODS OF TREATING CANCER WITH DENDRITIC CELL MOBILIZING AGENTS [Right-click to bookmark this link] | Status | Examination is in progress Status updated on 03.11.2023 Database last updated on 18.01.2025 | |
| Former | Request for examination was made Status updated on 30.10.2020 | ||
| Former | The international publication has been made Status updated on 03.08.2019 | ||
| Former | unknown Status updated on 16.03.2019 | Most recent event Tooltip | 06.05.2024 | New entry: Reply to examination report | Applicant(s) | For all designated states Celldex Therapeutics, Inc. 53 Frontage Road, Suite 220 Hampton, NJ 08827 / US | For all designated states Montefiore Medical Center 111 East 210th Street Bronx, NY 10467 / US | For all designated states Albert Einstein College of Medicine 1300 Morris Park Avenue Bronx, NY 10461 / US | [2020/49] | Inventor(s) | 01 /
KELER, Tibor 53 Frontage Road, Suite 220 Hampton, NJ 08827 / US | 02 /
YELLIN, Michael 138 Buckingham Road Montclair, NJ 07043 / US | 03 /
GUHA, Chandan 111 East 210 Street Bronx, NY 10467 / US | 04 /
OHRI, Nitin 111 East 210 Street Bronx, NY 10467 / US | [2020/49] | Representative(s) | J A Kemp LLP 80 Turnmill Street London EC1M 5QU / GB | [N/P] |
| Former [2020/49] | J A Kemp LLP 14 South Square Gray's Inn London WC1R 5JJ / GB | Application number, filing date | 19708908.9 | 25.01.2019 | [2020/49] | WO2019US15215 | Priority number, date | US201862622474P | 26.01.2018 Original published format: US 201862622474 P | [2020/49] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2019147982 | Date: | 01.08.2019 | Language: | EN | [2019/31] | Type: | A1 Application with search report | No.: | EP3743095 | Date: | 02.12.2020 | Language: | EN | The application published by WIPO in one of the EPO official languages on 01.08.2019 takes the place of the publication of the European patent application. | [2020/49] | Search report(s) | International search report - published on: | EP | 01.08.2019 | Classification | IPC: | A61K38/19 | [2020/49] | CPC: |
A61K45/06 (EP,US);
A61N5/1084 (US);
A61K38/177 (EP,US);
A61K39/3955 (US);
A61P35/00 (US);
C07K16/2818 (US);
C07K16/2827 (US);
C07K16/2875 (US);
A61K2039/505 (EP);
A61K2039/507 (US);
A61K2039/545 (US);
A61N5/10 (EP);
| C-Set: |
A61K38/177, A61K2300/00 (EP)
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2020/49] | Title | German: | VERFAHREN ZUR BEHANDLUNG VON KREBS MIT DENDRITISCHEN ZELLMOBILISIERUNGSMITTELN | [2020/49] | English: | METHODS OF TREATING CANCER WITH DENDRITIC CELL MOBILIZING AGENTS | [2020/49] | French: | MÉTHODES DE TRAITEMENT DU CANCER À L'AIDE D'AGENTS MOBILISATEUR DE CELLULES DENDRITIQUES | [2020/49] | Entry into regional phase | 03.08.2020 | National basic fee paid | 03.08.2020 | Designation fee(s) paid | 03.08.2020 | Examination fee paid | Examination procedure | 03.08.2020 | Examination requested [2020/49] | 03.08.2020 | Date on which the examining division has become responsible | 10.03.2021 | Amendment by applicant (claims and/or description) | 03.11.2023 | Despatch of a communication from the examining division (Time limit: M06) | 03.05.2024 | Reply to a communication from the examining division | Fees paid | Renewal fee | 03.08.2020 | Renewal fee patent year 03 | 27.01.2022 | Renewal fee patent year 04 | 27.01.2023 | Renewal fee patent year 05 | 29.01.2024 | Renewal fee patent year 06 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [I]WO2017118866 (REPLIMUNE LTD [GB]) [I] 1-25 * page 5, line 3 - page 6, paragraph 17 * * page 19, line 18 - page 21, line 5 * * page 28, line 13 - line 32; examples 2, 3, 11, 13 *; | [XI]WO2017147553 (MEMORIAL SLOAN KETTERING CANCER CENTER [US]) [X] 5,6,9,10,12 * page 7, line 27 - page 9, line 26 * * page 16, line 33 - page 17, line 17 * * page 29, line 26 - page 30, line 33 * * page 37, line 15 - line 28; examples 6, 7, 9-14 * * page 36, line 27 - page 37, line 14 * [I] 1-4,7,8,11,13-25; | [XI] - Linda Hammerich et al., "In situ vaccination improves efficacy of PD-1 blockade in unresponsive lymphoma tumors through induction of a highly efficient cross-presenting dendritic cell subset expressing TLR3", BLOOD (625. Lymphoma: Pre-Clinical-Chemotherapy and Biologic Agents: Poster III), vol. 130, no. Supp 1, (20171207), Database accession no. 4106, URL: http://www.bloodjournal.org/content/130/Suppl_1/4106.abstract?sso-checked=true, (20190401), XP002790227 [X] 1-7,9,12 * the whole document * [I] 8,10,11,13-25 | [XI] - M. A. CURRAN ET AL, "Tumor Vaccines Expressing Flt3 Ligand Synergize with CTLA-4 Blockade to Reject Preimplanted Tumors", CANCER RESEARCH, (20090908), vol. 69, no. 19, doi:10.1158/0008-5472.CAN-08-3289, ISSN 0008-5472, pages 7747 - 7755, XP055177400 [X] 5,9,13 * page 2, paragraph 4 * * page 3, paragraph 3 * * page 4, paragraph 3 * * page 5, paragraph 4 * * page 6, paragraph 5 - page 8, paragraph l * [I] 1-4,6-8,10-12,14-25 DOI: http://dx.doi.org/10.1158/0008-5472.CAN-08-3289 | [XI] - J. DURAISWAMY ET AL, "Therapeutic PD-1 Pathway Blockade Augments with Other Modalities of Immunotherapy T-Cell Function to Prevent Immune Decline in Ovarian Cancer", CANCER RESEARCH, (20131201), vol. 73, no. 23, doi:10.1158/0008-5472.CAN-13-1550, ISSN 0008-5472, pages 6900 - 6912, XP055179871 [X] 5,9,13,23 * page 6901, column r, paragraph 3 - page 6902, column l, paragraph 1 * * page 6907, column l, paragraph 3 - page 6909, column l, paragraph 1 * [I] 6,8,10,12,14-16 DOI: http://dx.doi.org/10.1158/0008-5472.CAN-13-1550 | [I] - PAOLA C. SACCO ET AL., "The combination of new immunotherapy and radiotherapy: A new potential treatment for locally advanced non-small cell lung cancer", CURRENT CLINICAL PHARMACOLOGY, (2017), vol. 12, pages 4 - 10, XP002790228 [I] 1-4,8-22,25 * page 7, column r, paragraph 2 * * page 8, column l, paragraph 2 - page 9, column r, paragraph 1 * | [XPI] - Nitin Ohri et al., "Abstract CT005: FLT3 ligand (CDX-301) and stereotactic radiotherapy for advanced non-small cell lung cancer", Cancer Research, vol. 78, no. 13, (20180701), URL: http://cancerres.aacrjournals.org/content/78/13_Supplement/CT005.short, (20190401), XP002790229 [XP] 2-4,6,7,9,11-16,20-22 * the whole document * [I] 8,10,17-19 | by applicant | US4518584 | EP0212914 | US4737462 | EP0276846 | US5011912 | US5071972 | US5199942 | US5554512 | US5843423 | US6632424 | WO2011070024 | WO2011107553 | WO2011131407 | WO2011140249 | WO2013087699 | WO2013119716 | WO2013132044 | WO2013169264 | WO2014036357 | - DEVEREUX et al., Nucl. Acids Res., (19840000), vol. 12, page 387 | - NEEDLEMAN; WUNSCH, J. Mol. Biol., (19700000), vol. 48, page 443 | - SMITH; WATERMAN, Adv. Appl. Math, (19810000), vol. 2, page 482 | - GRIBSKOY; BURGESS, Nucl. Acids Res., (19860000), vol. 14, page 6745 | - Atlas of Protein Sequence and Structure, National Biomedical Research Foundation, (19790000), pages 353 - 358 | - FLEMING et al., Blood, (19990000), vol. 94, page 49a | - WALDER et al., Gene, (19860000), vol. 42, page 133 | - BAUER et al., Gene, (19850000), vol. 37, page 73 | - CRAIK, BioTechniques, (19850100), pages 12 - 19 | - KUNKEL, Proc. Natl. Acad. Sci. USA, (19850000), vol. 82, page 488 | - KUNKEL et al., Methods in Enzymol., (19870000), vol. 154, page 367 | - SAMBROOK et al., Molecular Cloning: A Laboratory Manual, Cold Spring Harbor Laboratory Press, (19890000), vol. 1, pages 1.101 - 104 | - E. VACCHELLI et al., Oncoimmnology, (20160000), vol. 5, page e1214790 | - C. VANPOUILLE-BOX et al., Nat Commin, (20170000), vol. 8, page 15618 | - TANSEY, Drug Discovery Today, (20090000), vol. 00, page 1 | - GARG AD, Int J Dev Biol, (20150000), vol. 59, page 131 | - FULDA et al., Nat Med, (20020000), vol. 8, pages 808 - 15 | - HYER et al., Cancer Research, (20050000), vol. 65, pages 4799 - 808 |